<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="chapter-article"><?DTDIdentifier.IdentifierValue http://null/schema/dtds/document/fulltext/xcr/xocs-article.xsd?><?DTDIdentifier.IdentifierType schema?><?SourceDTD.DTDName xocs-article.xsd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName ftrr2jats.xsl?><?ConverterInfo.Version 1?><?origin publisher?><front><?noissn?><journal-meta><journal-id journal-id-type="nlm-ta">Hunter's Tropical Medicine and Emerging Infectious Diseases</journal-id><journal-title-group><journal-title>Hunter's Tropical Medicine and Emerging Infectious Diseases</journal-title></journal-title-group></journal-meta><article-meta><article-id pub-id-type="pmcid">7152027</article-id><article-id pub-id-type="publisher-id">B978-0-323-55512-8.00150-2</article-id><article-id pub-id-type="doi">10.1016/B978-0-323-55512-8.00150-2</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Fever in the Returned Traveler</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0010"><name><surname>Marks</surname><given-names>Michael</given-names></name></contrib><contrib contrib-type="author" id="au0015"><name><surname>Johnston</surname><given-names>Victoria</given-names></name></contrib><contrib contrib-type="author" id="au0020"><name><surname>Brown</surname><given-names>Michael</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Ryan</surname><given-names>Edward T.</given-names></name><degrees>MD, FACP, FIDSA, FASTMH, FAAM</degrees></contrib></contrib-group><aff>Professor of Medicine, Professor of Immunology and Infectious Diseases, Harvard University</aff><aff>Director, Global Infectious Diseases, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA</aff><contrib-group><contrib contrib-type="editor"><name><surname>Hill</surname><given-names>David R.</given-names></name><degrees>MD, DTM &#x00026; H, FRCP, FFTM (RCPS Glasg), FASTMH</degrees></contrib></contrib-group><aff>Professor of Medical Sciences, Director of Global Public Health, Frank H. Netter MD School of Medicine, Quinnipiac University, Hamden, CT, USA</aff><contrib-group><contrib contrib-type="editor"><name><surname>Solomon</surname><given-names>Tom</given-names></name><degrees>BA, BM, BCh, FRCP, DCH, DTM &#x00026; H, PhD</degrees></contrib></contrib-group><aff>Professor of Neurological Science, Walton Centre NHS, Foundation Trust, Director, National Institute for Health Research Health, Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK</aff><contrib-group><contrib contrib-type="editor"><name><surname>Aronson</surname><given-names>Naomi E.</given-names></name><degrees>MD</degrees></contrib></contrib-group><aff>Professor of Medicine, Director, Infectious Diseases Division, Uniformed Services University of the Health Sciences, Bethesda, MD, USA</aff><contrib-group><contrib contrib-type="editor"><name><surname>Endy</surname><given-names>Timothy P.</given-names></name><degrees>MD, MPH, FACP, FIDSA, FASTMH</degrees></contrib></contrib-group><aff>Professor and Chair, Microbiology and Immunology, State University of New York Upstate, Medical University, Syracuse, NY, USA</aff><pub-date pub-type="pmc-release"><day>28</day><month>5</month><year>2019</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="ppub"><year>2020</year></pub-date><pub-date pub-type="epub"><day>28</day><month>5</month><year>2019</year></pub-date><fpage>1077</fpage><lpage>1086</lpage><permissions><copyright-statement>Copyright &#x000a9; 2020 Elsevier Inc. All rights reserved.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Elsevier Inc.</copyright-holder><license><license-p>Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</license-p></license></permissions><abstract id="ab0010"><p>International travel is associated with a risk of infections not typically seen in high-income settings. Malaria is the most important tropical infection in travelers, but epidemics of dengue, chikungunya, and Zika emphasize that clinicians need to be aware of the rapidly changing distribution of many arboviruses. A detailed travel history and a syndromic approach to the investigation and management of patients is key. Consultation with a specialist is often recommended to ensure that appropriate management and investigations are undertaken in febrile returned travelers.</p></abstract><kwd-group id="kwd0010"><title>Keywords</title><kwd>malaria</kwd><kwd>visiting friends and relatives</kwd><kwd>travelers</kwd><kwd>imported infections</kwd><kwd>arboviruses</kwd><kwd>fever</kwd><kwd>skin rash</kwd><kwd>diarrhea</kwd><kwd>respiratory tract infection</kwd><kwd>incubation period</kwd><kwd>extended spectrum beta-lactamase</kwd><kwd>incubation period</kwd><kwd>geographic risk</kwd><kwd>enteric fever</kwd><kwd>dengue</kwd><kwd>salmonella</kwd><kwd>rickettsia</kwd><kwd>encephalitis</kwd><kwd>hepatitis</kwd><kwd>tuberculosis</kwd></kwd-group></article-meta></front><body><sec id="s0010"><title>Introduction</title><p id="p0045">Up to 70% of travelers to low-income regions report health problems, the majority of which are self-limiting; however 8% to 15% of travelers are ill enough to seek medical attention while abroad or on return home, with fever a common presenting complaint.<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref>, <xref rid="bib3" ref-type="bibr">3</xref> The etiology is often a self-limiting, globally endemic infection, such as influenza or gastroenteritis; however, conditions not normally seen in the patient's country of origin are increasingly seen. These can be life threatening, such as malaria, and others can have public health consequences, such as enteric fever.</p><p id="p0050">To evaluate febrile returned travelers, it is necessary to have an understanding of the geographic distribution of infections, risk factors for acquisition, incubation periods, and clinical presentations. A risk assessment can then be made, initial investigations instigated, and, when appropriate, presumptive therapy started.</p></sec><sec id="s0015"><title>Epidemiology</title><p id="p0055">The epidemiology of fever in returned travelers reflects factors relating to the individual traveler and to the wide spectrum of etiologic pathogens. Many pathogens&#x02014;for example, influenza&#x02014;have a global distribution; however, others are only found in distinct geographic locations. Among patients with undifferentiated fever, malaria, dengue, and enteric fever are the most common tropical diagnoses.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> The following factors influence an individual's risk of acquiring infection (<xref rid="t0010" ref-type="table">Table 150.1</xref>
).<xref rid="bib5" ref-type="bibr"><sup>4</sup></xref>
<table-wrap position="float" id="t0010"><label>TABLE 150.1</label><caption><p>Causes of Fever Associated With Geographic Areas and Specific Risk Factors</p></caption><alt-text id="atte0025">TABLE 150.1</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Risk Factor</th><th align="left">Common</th><th align="left">Occasional</th><th align="left">Rare but Important</th></tr></thead><tbody><tr><td colspan="4" align="left"><bold>G<sc>eographic</sc> A<sc>rea</sc></bold></td></tr><tr><td align="left">Sub-Saharan Africa</td><td align="left">HIV-associated infections (including seroconversion)<break/>Malaria<break/>Rickettsiae</td><td align="left">Acute schistosomiasis<break/>(Katayama)<break/>Amebic liver abscess<break/>Brucellosis<break/>Dengue<break/>Enteric fever<break/>Meningococcus</td><td align="left">Histoplasmosis<break/>Other arbovirus (e.g., Rift Valley, West Nile fever, yellow fever)<break/>Trypanosomiasis<break/>Viral hemorrhagic fever (Lassa, Ebola, Marburg, CCHF)<break/>Visceral leishmaniasis</td></tr><tr><td colspan="4"><hr/></td></tr><tr><td align="left">North Africa, Middle East, and Mediterranean</td><td align="left"/><td align="left">Brucellosis<break/>Q fever<break/>Toscana (sandfly fever)<break/>MERS</td><td align="left">Visceral leishmaniasis</td></tr><tr><td colspan="4"><hr/></td></tr><tr><td align="left">Eastern Europe and Scandinavia</td><td align="left"/><td align="left">Lyme disease</td><td align="left">Hantavirus<break/>Tick-borne encephalitis<break/>Tularemia</td></tr><tr><td colspan="4"><hr/></td></tr><tr><td align="left">Central Asia</td><td align="left"/><td align="left">Q fever<break/>Rickettsia<break/>Sandfly fever</td><td align="left"/></tr><tr><td colspan="4"><hr/></td></tr><tr><td align="left">South Asia</td><td align="left">Dengue<break/>Enteric fever<break/>Malaria</td><td align="left">Chikungunya<break/>Visceral leishmaniasis</td><td align="left">CCHF<break/>Japanese encephalitis<break/>Other arbovirus (Nipah virus)<break/>Rickettsiae</td></tr><tr><td colspan="4"><hr/></td></tr><tr><td align="left">Southeast Asia</td><td align="left">Chikungunya<break/>Dengue<break/>Zika (emerging)<break/>Enteric fever<break/>Malaria</td><td align="left">Leptospirosis<break/>Melioidosis</td><td align="left">Hantavirus<break/>Japanese encephalitis<break/>Other arbovirus<break/>Nipah virus<break/>Paragonimiasis<break/>Penicilliosis<break/>Scrub typhus</td></tr><tr><td colspan="4"><hr/></td></tr><tr><td align="left">North Australia</td><td align="left"/><td align="left">Dengue<break/>Murray Valley<break/>Q fever<break/>Rickettsiae<break/>Ross River fever</td><td align="left">Barmah Forest<break/>Melioidosis</td></tr><tr><td colspan="4"><hr/></td></tr><tr><td align="left">Latin America and Caribbean</td><td align="left">Dengue<break/>Enteric fever<break/>Malaria<break/>Chikungunya<break/>Zika</td><td align="left">Brucellosis<break/>Paracoccidioidomycosis<break/>Histoplasmosis<break/>Leptospirosis</td><td align="left">Acute trypanosomiasis (Chagas)<break/>Hanta virus<break/>Yellow fever</td></tr><tr><td colspan="4"><hr/></td></tr><tr><td align="left">North America</td><td align="left"/><td align="left">Coccidioidomycosis<break/>Histoplasmosis<break/>Lyme disease<break/>Rocky Mountain spotted fever</td><td align="left">Babesiosis<break/>Anaplasmosis<break/>Ehrlichiosis<break/>West Nile fever</td></tr><tr><td colspan="4"><hr/></td></tr><tr><td colspan="4" align="left"><bold>S<sc>pecific</sc> R<sc>isk</sc> F<sc>actors</sc></bold></td></tr><tr><td align="left">Game parks</td><td align="left">African tick typhus</td><td align="left"/><td align="left">Anthrax<break/>Trypanosomiasis</td></tr><tr><td colspan="4"><hr/></td></tr><tr><td align="left">Freshwater exposure</td><td align="left"/><td align="left">Acute schistosomiasis<break/>Leptospirosis</td><td align="left"/></tr><tr><td align="left">Caves</td><td align="left"/><td align="left">Histoplasmosis</td><td align="left">Marburg<break/>Rabies</td></tr><tr><td colspan="4"><hr/></td></tr><tr><td align="left">HIV</td><td align="left">Amebiasis<break/>Non-typhoidal salmonella<break/>Tuberculosis</td><td align="left">STI (e.g., syphilis)<break/>Visceral leishmaniasis</td><td align="left">Blastomycosis<break/>Coccidioidomycosis<break/>Histoplasmosis<break/>Penicilliosis</td></tr></tbody></table><table-wrap-foot><fn><p><italic>CCHF</italic>, Crimean-Congo hemorrhagic fever; <italic>MERS,</italic> Middle Eastern Respiratory Syndrome; <italic>STI</italic>, sexually transmitted infection.</p></fn></table-wrap-foot><attrib>Table adapted with permission from British Infection Society. Fever in returned travelers presenting in the United Kingdom: recommendations for investigation and initial management.<xref rid="bib7" ref-type="bibr"><sup>5</sup></xref></attrib></table-wrap></p><sec id="s0020"><title>Individual Factors</title><p id="p0065">
<list list-type="simple" id="ulist0015"><list-item id="u0040"><label>&#x02022;</label><p id="p0070">
<italic>Purpose and duration of travel:</italic> Individuals visiting friends and relations (VFR) and long-stay travelers (e.g., aid workers) are at greatest risk of acquiring malaria, enteric fever, hepatitis A, tuberculosis, and sexually transmitted infections (STIs), including HIV. This is partly due to longer duration of travel and closer proximity to the local population.</p></list-item><list-item id="u0045"><label>&#x02022;</label><p id="p0075">
<italic>Immune status:</italic> Migrants returning to their home countries may be immune to certain infections, such as hepatitis A and acute schistosomiasis; however, they may incorrectly consider themselves immune to others, such as malaria. Consequently, VFR travelers are less likely to seek pre-travel advice, take malaria prophylaxis, or receive vaccines.<xref rid="bib5" ref-type="bibr"><sup>4</sup></xref> Travelers with HIV, malignancy, or on immunosuppressant drugs are at increased risk of opportunistic infections, including non-typhoidal <italic>Salmonella</italic> and penicilliosis.</p></list-item><list-item id="u0050"><label>&#x02022;</label><p id="p0080">
<italic>Risk activities:</italic> Certain activities are an exposure risk (e.g., freshwater swimming and schistosomiasis, unprotected sexual intercourse and HIV).</p></list-item></list>
</p></sec><sec id="s0025"><title>Pathogen Factors</title><p id="p0085">
<list list-type="simple" id="ulist0020"><list-item id="u0055"><label>&#x02022;</label><p id="p0090">
<italic>Geographic distribution:</italic> Risk varies with country and environment (e.g., urban or rural, mountains or coastal plains). Although malaria is the most common infection diagnosed in travelers returned from sub-Saharan Africa, dengue is more prevalent in travelers returning from Southeast Asia and enteric fever from southcentral Asia (see <xref rid="t0010" ref-type="table">Table 150.1</xref>).</p></list-item><list-item id="u0060"><label>&#x02022;</label><p id="p0095">
<italic>Incubation period:</italic> Most travelers become symptomatic within 21 days of exposure, with the majority presenting within 1 month of return. However, some pathogens have a much longer incubation period (e.g., <italic>Plasmodium vivax</italic> and tuberculosis); patients can present months or, rarely, years later (<xref rid="t0015" ref-type="table">Table 150.2</xref>
).<table-wrap position="float" id="t0015"><label>TABLE 150.2</label><caption><p>Incubation Periods of Infections</p></caption><alt-text id="atte0030">TABLE 150.2</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Incubation Period</th><th align="left">Infection</th></tr></thead><tbody><tr><td align="left">Short (&#x0003c;10 days)</td><td align="left">Arboviral infections (e.g., dengue, chikungunya, Zika)<break/>Gastroenteritis, acute (bacterial, viral)<break/>Melioidosis<break/>Meningitis (bacterial, viral)<break/>Relapsing fever (<italic>Borrelia</italic> spp.)<break/>Respiratory tract infection (bacterial, viral including H1N1, avian influenza, and MERS)<break/>Rickettsial infection (e.g., tick typhus, scrub typhus)</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Medium (10&#x02013;21 days)</td><td align="left">Bacterial<break/><list list-type="simple" id="ulist0025"><list-item id="u0065"><label>&#x02022;</label><p id="p0100">Brucellosis</p></list-item><list-item id="u0070"><label>&#x02022;</label><p id="p0105">Enteric fever (typhoid and paratyphoid fever)</p></list-item><list-item id="u0075"><label>&#x02022;</label><p id="p0110">Leptospirosis</p></list-item><list-item id="u0080"><label>&#x02022;</label><p id="p0115">Melioidosis</p></list-item><list-item id="u0085"><label>&#x02022;</label><p id="p0120">Q fever (<italic>Coxiella burnetii</italic>)</p></list-item></list><break/>Fungal<break/><list list-type="simple" id="ulist0030"><list-item id="u0090"><label>&#x02022;</label><p id="p0125">Coccidioidomycosis</p></list-item><list-item id="u0095"><label>&#x02022;</label><p id="p0130">Histoplasmosis (can be as short as 3 days)</p></list-item></list><break/>Protozoal<break/><list list-type="simple" id="ulist0035"><list-item id="u0100"><label>&#x02022;</label><p id="p0135">Chagas disease, acute</p></list-item><list-item id="u0105"><label>&#x02022;</label><p id="p0140">Malaria (<italic>Plasmodium falciparum</italic>)</p></list-item><list-item id="u0110"><label>&#x02022;</label><p id="p0145">
<italic>Trypanosoma rhodesiense</italic>
</p></list-item></list><break/>Viral<break/><list list-type="simple" id="ulist0040"><list-item id="u0115"><label>&#x02022;</label><p id="p0150">CMV, EBV, HIV, viral hemorrhagic fevers</p></list-item></list></td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Long (&#x0003e;21 days)</td><td align="left">Bacterial<break/><list list-type="simple" id="ulist0045"><list-item id="u0120"><label>&#x02022;</label><p id="p0155">Brucellosis</p></list-item><list-item id="u0125"><label>&#x02022;</label><p id="p0160">Tuberculosis</p></list-item></list><break/>Fluke<break/><list list-type="simple" id="ulist0050"><list-item id="u0130"><label>&#x02022;</label><p id="p0165">Schistosomiasis, acute</p></list-item></list><break/>Protozoal<break/><list list-type="simple" id="ulist0055"><list-item id="u0135"><label>&#x02022;</label><p id="p0170">Amebic liver abscess</p></list-item><list-item id="u0140"><label>&#x02022;</label><p id="p0175">Malaria (including <italic>P. falciparum</italic>)</p></list-item><list-item id="u0145"><label>&#x02022;</label><p id="p0180">
<italic>T. gambiense</italic>
</p></list-item><list-item id="u0150"><label>&#x02022;</label><p id="p0185">Visceral leishmaniasis</p></list-item></list><break/>Viral<break/><list list-type="simple" id="ulist0060"><list-item id="u0155"><label>&#x02022;</label><p id="p0190">HIV</p></list-item><list-item id="u0160"><label>&#x02022;</label><p id="p0195">Viral hepatitis (A&#x02013;E)</p></list-item></list></td></tr></tbody></table><table-wrap-foot><fn><p><italic>CMV</italic>, Cytomegalovirus; <italic>EBV</italic>, Epstein&#x02013;Barr virus; <italic>HIV</italic>, human immunodeficiency virus; <italic>MERS</italic>, Middle Eastern Respiratory Syndrome.</p></fn></table-wrap-foot><attrib>Table adapted with permission from British Infection Society. Fever in returned travelers presenting in the United Kingdom: recommendations for investigation and initial management.<xref rid="bib7" ref-type="bibr"><sup>5</sup></xref></attrib></table-wrap></p></list-item></list>
</p></sec></sec><sec id="s0030"><title>Clinical Features</title><p id="p0200">Patients can present with undifferentiated fever or with organ-specific symptoms, such as gastroenteritis or respiratory infection. For more detailed descriptions, relevant chapters on specific infections should be consulted.</p><sec id="s0035"><title>Undifferentiated Fever</title><sec id="s0040"><title>Malaria</title><p id="p0205">Malaria is a potentially fatal infection in travelers returning from the tropics, particularly from sub-Saharan Africa.<xref rid="bib7" ref-type="bibr"><sup>5</sup></xref> It should be excluded in all travelers with a history of fever. The risk of travelers acquiring malaria outside sub-Saharan Africa has decreased substantially in recent years, especially in those from India and South America.<xref rid="bib8" ref-type="bibr"><sup>6</sup></xref> Most short-term travelers present within 1 month of return; however, <italic>P. falciparum</italic> occasionally presents up to 6 months later, and <italic>P. vivax, P. ovale,</italic> and <italic>P. malariae</italic> can present a year or more after return.<xref rid="bib9" ref-type="bibr"><sup>7</sup></xref> Many travelers do not take chemoprophylaxis, or take it inadequately.<xref rid="bib5" ref-type="bibr"><sup>4</sup></xref> When malaria is acquired despite chemoprophylaxis, the onset of symptoms is often delayed, severity of illness reduced, and microbiologic diagnosis may be obscured.<xref rid="bib10" ref-type="bibr"><sup>8</sup></xref> Chemoprophylaxis can obscure the diagnosis, so in cases where malaria is thought likely, chemoprophylaxis can be stopped while patients are investigated.<xref rid="bib7" ref-type="bibr"><sup>5</sup></xref>
</p><p id="p0210">Nearly all patients with malaria give a history of fever; however, up to half are afebrile on presentation, although specific fever patterns are uncommon.<xref rid="bib11" ref-type="bibr"><sup>9</sup></xref> Headache, myalgia, arthralgia, and malaise are frequently described, and some patients report diarrhea or cough. Complications occur mainly with <italic>P. falciparum</italic> infection but can also occur after infection with <italic>P. vivax</italic> and <italic>P. knowlesi.</italic> In patients with confusion, seizures, or reduced consciousness level, cerebral malaria or hypoglycemia should be considered; hypoxia, tachypnea, and signs of pulmonary edema indicate respiratory involvement.</p></sec><sec id="s0045"><title>Enteric Fever (<italic>Salmonella</italic> Typhi, <italic>S.</italic> Paratyphi)</title><p id="p0215">Enteric fever is a potentially life-threatening infection that requires early diagnosis and management. It is seen particularly in VFR travelers returning from Asia,<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> although there have been outbreaks in Malawi and Kenya, and this may translate into more imported cases.<xref rid="bib12" ref-type="bibr"><sup>10</sup></xref> With an incubation period of 7 to 18 days (range up to 60 days), most patients present within a month of return. A history of vaccination pre-travel has little predictive value; it provides incomplete protection against <italic>S.</italic> Typhi and no protection against <italic>S.</italic> Paratyphi.</p><p id="p0220">In addition to fever, symptoms include headache, constipation/diarrhea, and dry cough. Complications, in particular encephalopathy and gastrointestinal bleeding and intestinal perforation, occur infrequently; they are more likely if the duration of illness is &#x0003e;2 weeks.</p></sec><sec id="s0050"><title>Rickettsiae</title><p id="p0225">The most common travel-associated rickettsial infections are due to <italic>Rickettsia africae</italic> (African tick typhus). Endemic throughout sub-Saharan Africa, it is a common diagnosis in those who have visited game parks in southern Africa. <italic>R. conorii</italic> (Mediterranean spotted fever or tick bite fever) is endemic throughout sub-Saharan Africa, the Mediterranean, Caspian littoral countries, the Indian subcontinent, and the Middle East. Travelers infected with <italic>R. typhi</italic> (murine typhus) and <italic>Orientia tsutsugamushi</italic> (scrub typhus) are rarely seen.</p><p id="p0230">Rickettsiae have an incubation period of 5 to 7 days (up to 10 days) and similar presentations. More than 80% of patients infected with <italic>R. africae</italic> or <italic>R. conorii</italic> describe fever, headache, and myalgia. The classic signs of inoculation eschar, rash, and lymphadenitis are seen in &#x0003c;50%; however, retrospective cohorts report higher rates (<xref rid="f0010" ref-type="fig">Fig. 150.1</xref>
).<xref rid="bib13" ref-type="bibr"><sup>11</sup></xref> Complications (e.g., reactive arthritis) are rarely encountered in African tick typhus; mortality rates of up to 32% have been reported for Mediterranean tick bite fever, 17% for scrub typhus, and 4% for murine typhus.<xref rid="bib14" ref-type="bibr">12</xref>, <xref rid="bib15" ref-type="bibr">13</xref>, <xref rid="bib16" ref-type="bibr">14</xref>
<fig id="f0010"><label>Fig. 150.1</label><caption><p>Patient returned 2 days previously from a safari holiday in Botswana. On further examination, an eschar was found. Diagnosis: African tick typhus.</p></caption><alt-text id="atte0010">Fig. 150.1</alt-text><graphic xlink:href="f150-001-9780323555128"/></fig></p></sec><sec id="s0055"><title>Arbovirus</title><p id="p0235">There are over 500 arthropod-borne viruses worldwide, although not all cause human disease. The majority are usually restricted to specific geographic locations; for example, Ross River virus in Australia. However, due to a combination of international travel and changes in vector distribution there have been changes in the distribution of many arboviruses. They have short incubation periods (&#x0003c;1 week) and result in self-limiting illnesses. Four clinical presentations predominate:<list list-type="simple" id="ulist0065"><list-item id="u0165"><label>&#x02022;</label><p id="p0240">Systemic febrile illness (e.g., all arboviruses)</p></list-item><list-item id="u0170"><label>&#x02022;</label><p id="p0245">Hemorrhagic fever (e.g., dengue, yellow fever, Rift Valley fever, Crimean-Congo hemorrhagic fever)</p></list-item><list-item id="u0175"><label>&#x02022;</label><p id="p0250">Acute encephalitis (e.g., Japanese encephalitis, Rift Valley fever, West Nile virus, Eastern and Western equine encephalitis viruses)</p></list-item><list-item id="u0180"><label>&#x02022;</label><p id="p0255">Polyarthralgia or arthritis (e.g., chikungunya, Ross River)</p></list-item></list>
</p><p id="p0260">Dengue is the most common arbovirus in travelers. Although widespread, it is a cause of fever mainly in those returning from Asia, the Caribbean, and South America.<xref rid="bib17" ref-type="bibr"><sup>15</sup></xref> Most travelers present with a febrile illness associated with headache, retro-orbital pain, myalgia, arthralgia (especially back pain), and rash.<xref rid="bib17" ref-type="bibr"><sup>15</sup></xref> The rash, initially erythrodermic, becomes petechial with disease progression (<xref rid="f0015" ref-type="fig">Fig. 150.2</xref>
). Hepatitis, myocarditis, encephalitis, and neuropathy can occur. Bleeding gums, epistaxis, and gastrointestinal bleeding occur but are not necessarily indicative of dengue hemorrhagic fever, which, like dengue shock syndrome, is rare in travelers.<fig id="f0015"><label>Fig. 150.2</label><caption><p>Patient returned 4 days previously from a beach holiday in Thailand. He describes developing &#x0201c;sunstroke&#x0201d; on the last day of his holiday (sunburn, headache, feverish). Symptoms have not settled. Diagnosis: dengue.</p></caption><alt-text id="atte0015">Fig. 150.2</alt-text><graphic xlink:href="f150-002-9780323555128"/></fig></p><p id="p0265">Chikungunya has a distribution similar to dengue with large epidemics in the Caribbean, South America, India, and Southeast Asia.<xref rid="bib18" ref-type="bibr"><sup>16</sup></xref> The clinical presentation is similar to classic dengue fever; however, arthralgia is more prominent. In the majority of cases, the arthralgia settles; 5% to 30% develop chronic arthropathy with pain, stiffness and swelling lasting months to years.<xref rid="bib19" ref-type="bibr">17</xref>, <xref rid="bib20" ref-type="bibr">18</xref>
</p><p id="p0270">Zika virus has caused large outbreaks in the Caribbean, South and Central America, and the Pacific and is increasingly reported in Asia.<xref rid="bib21" ref-type="bibr"><sup>19</sup></xref> Acutely, the disease is similar to dengue. However, Guillain&#x02013;Barr&#x000e9; syndrome can be a complication, and during pregnancy Zika can lead to stillbirth and is associated with congenital abnormalities, including fetal microcephaly. Sexual transmission of Zika is well described.<xref rid="bib21" ref-type="bibr"><sup>19</sup></xref> No clinical features reliably distinguish dengue, chikungunya, and Zika infection, although thrombocytopenia is normally more pronounced in dengue.<xref rid="bib22" ref-type="bibr"><sup>20</sup></xref>
</p><p id="p0275">Large outbreaks of yellow fever continue to occur in both Africa and South America and may be associated with an increased risk of imported cases among travelers.</p></sec><sec id="s0060"><title>Acute Schistosomiasis (Katayama Fever)</title><p id="p0280">This should be considered in febrile travelers returning from Africa. Travelers give a history of freshwater exposure 4 to 6 weeks (up to 9) before symptom onset. Some describe a self-resolving itchy rash immediately after exposure (swimmer's itch). Symptoms and signs include fever, lethargy, myalgia, arthralgia, cough, wheeze, headache, urticarial rash, diarrhea, and hepatosplenomegaly.<xref rid="bib23" ref-type="bibr"><sup>21</sup></xref> The eosinophil count is usually elevated with acute schistosomiasis and provides supportive evidence for the diagnosis, but it may only appear a few days after symptom onset. Acute symptoms are self-limiting in most cases.</p></sec><sec id="s0065"><title>Leptospirosis</title><p id="p0285">Leptospirosis has a global distribution. Infection occurs after exposure to rodent or dog urine&#x02013;contaminated freshwater; for example, through recreational water sports, flooding, or occupation. After an incubation period of 7 to 12 days, patients classically present with a biphasic illness: a bacteremic phase with flulike symptoms lasting 4 to 7 days, followed 1 to 3 days later by an immune phase of fever, myalgia, hepatorenal syndrome, and hemorrhage.<xref rid="bib24" ref-type="bibr"><sup>22</sup></xref> The severe end of the spectrum, Weil's disease, occurs infrequently but has a case fatality rate of 10% to 15%. Gastrointestinal and respiratory presentations and meningitis, myocarditis, and pancreatitis are occasionally described.</p></sec><sec id="s0070"><title>Amebic Liver Abscess</title><p id="p0290">Amebic liver abscess<xref rid="bib25" ref-type="bibr"><sup>23</sup></xref> should be considered in all patients with fever and a raised right hemi-diaphragm on chest radiography. It has a higher prevalence in developing countries. Travelers, exposed through fecal&#x02013;oral transmission, will often present weeks to months after return (incubation period: 8&#x02013;20 weeks). Most patients report fever, often localized abdominal pain, and hepatomegaly. Only 20% give a history of dysentery, and only 10% have diarrhea at presentation.</p></sec><sec id="s0075"><title>Brucellosis</title><p id="p0295">Brucellosis<xref rid="bib26" ref-type="bibr"><sup>24</sup></xref> is acquired through ingestion of unpasteurized milk, although transmission can occur after direct contact with animal parts or, in laboratories, through inhalation of aerosolized particles. It has a global distribution, with a higher prevalence in the Middle East, Balkans, former USSR, the Mediterranean, and South America. Symptoms develop 2 to 4 weeks after exposure (up to 6 months) and vary from an acute febrile illness to a chronic low-grade relapsing fever; signs include lymphadenopathy, hepatomegaly, and splenomegaly. Complications of brucellosis are common&#x02014;in particular, large-joint septic arthritis, sacroiliitis, and, less commonly, spondylitis of the lumbar spine. Other complications include epididymo-orchitis, septic abortion, neurologic involvement (meningitis, encephalitis, and abscess), and endocarditis.</p></sec><sec id="s0080"><title>Q Fever (<italic>Coxiella burnetii</italic>&#x02009;)</title><p id="p0300">Q fever<xref rid="bib27" ref-type="bibr"><sup>25</sup></xref> is rarer than brucellosis, although it has a similar clinical history. It has a global distribution, with most cases related to occupational exposure, usually through inhalation of aerosolized particles. Community outbreaks, as reported in the Netherlands in 2008, occur.<xref rid="bib28" ref-type="bibr"><sup>26</sup></xref> Most cases are asymptomatic; symptomatic patients present with fever, pneumonia, or hepatitis after exposure to farms or animals. Complications, including chronic infection, are well described, particularly endocarditis.</p></sec><sec id="s0085"><title>HIV and Other STIs</title><p id="p0305">Between 5% and 51% of short-term travelers take part in casual sex while abroad, with higher rates reported in long-term travelers.<xref rid="bib29" ref-type="bibr"><sup>27</sup></xref> Many STIs present as a febrile illness, including HIV seroconversion, secondary syphilis (<xref rid="f0020" ref-type="fig">Fig. 150.3</xref>
), and gonorrhea. People living with HIV who travel to the tropics can be at increased risk of opportunistic infections (see <xref rid="t0010" ref-type="table">Table 150.1</xref>).<xref rid="bib30" ref-type="bibr"><sup>28</sup></xref>
<fig id="f0020"><label>Fig. 150.3</label><caption><p>Patient returned 1 month previously from a 2-week holiday in Thailand. Two days prior to presentation, he developed fever, headache, and rash. On further questioning, he reported having unprotected sexual intercourse during his holiday. Diagnosis: secondary syphilis.</p></caption><alt-text id="atte0020">Fig. 150.3</alt-text><graphic xlink:href="f150-003-9780323555128"/></fig></p></sec></sec><sec id="s0090"><title>Respiratory Tract Infections</title><p id="p0310">Respiratory tract infections are diagnosed as the underlying cause of febrile illness in 7% to 24% of returning travelers.<xref rid="bib5" ref-type="bibr"><sup>4</sup></xref> These include sinusitis, pharyngitis, tonsillitis, bronchitis, influenza, pneumonia, and pulmonary eosinophilia. Influenza is the most common vaccine-preventable infection acquired by travelers. The following are clinical and epidemiologic associations (see disease-specific chapters for details).</p><sec id="s0095"><title>Upper Respiratory Tract Infections</title><p id="p0315">
<list list-type="simple" id="ulist0070"><list-item id="u0185"><label>&#x02022;</label><p id="p0320">Diphtheria: Patients with severe pharyngitis on return from the Indian subcontinent, Southeast Asia, Haiti, or South America.</p></list-item></list>
</p></sec><sec id="s0100"><title>Lower Respiratory Tract Infections</title><p id="p0325">
<list list-type="simple" id="ulist0075"><list-item id="u0190"><label>&#x02022;</label><p id="p0330">Middle Eastern Respiratory Syndrome (MERS), caused by a coronavirus, is a severe acute respiratory illness. Nosocomial transmission is well documented, so strict respiratory precautions must be initiated. Camels are known to be the reservoir.<xref rid="bib31" ref-type="bibr"><sup>29</sup></xref>
</p></list-item><list-item id="u0195"><label>&#x02022;</label><p id="p0335">Histoplasmosis or coccidioidomycosis: Exposure to damp conditions (e.g., bat-occupied caves) or dusty conditions, respectively. Coccidioidomycosis is restricted to certain areas in the Americas.</p></list-item><list-item id="u0200"><label>&#x02022;</label><p id="p0340">Legionella: Exposure to air conditioning or other aerosolized water sources in cruise ships or hotels.</p></list-item><list-item id="u0205"><label>&#x02022;</label><p id="p0345">Melioidosis (<italic>Burkholderia pseudomallei</italic>): Febrile patients from Southeast Asia with upper lung zone infiltrates or cavitation on chest radiography or septicemia.</p></list-item><list-item id="u0210"><label>&#x02022;</label><p id="p0350">Q fever: Fever, pneumonia, or hepatitis after exposure to farms or animals.</p></list-item><list-item id="u0215"><label>&#x02022;</label><p id="p0355">Tuberculosis: Travel to areas of high endemicity, particularly among VFRs, long-stay travelers, health care workers, and the immune compromised; symptomatic primary infection is uncommon.<xref rid="bib32" ref-type="bibr"><sup>30</sup></xref>
</p></list-item><list-item id="u0220"><label>&#x02022;</label><p id="p0360">Fever, respiratory symptoms, and peripheral eosinophilia: Consider Loeffler's syndrome (<italic>Ascaris,</italic> hookworm, <italic>Strongyloides</italic>), acute schistosomiasis, tropical pulmonary eosinophilia (filaria), leaking hydatid cyst, visceral larva migrans, and paragonimiasis.<xref rid="bib33" ref-type="bibr"><sup>31</sup></xref>
</p></list-item></list>
</p></sec></sec><sec id="s0105"><title>Gastrointestinal Infections</title><sec id="s0110"><title>Diarrhea</title><p id="p0365">Travelers&#x02019; diarrhea has a reported incidence of at least 200 cases/1000 ill returned travelers.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> Fever is self-reported in one third of these patients. Specific pathogens vary according to destination, setting, and season; however, enteric bacteria, including <italic>Escherichia coli, Campylobacter, Salmonella,</italic> and <italic>Shigella,</italic> are the most common. In up to 50%, no pathogen is identified. The combination of fever and bloody diarrhea is suggestive of bacterial or amebic dysentery, with the latter (uncommon in the returning traveler) often having a more indolent onset. Empiric antibiotics can be considered (see later). Any systemic febrile infection can have diarrhea at presentation; for example, severe sepsis, malaria, and pneumococcal pneumonia.</p></sec><sec id="s0115"><title>Abdominal Pain</title><p id="p0370">Enteric fever, amebic liver abscess, viral hepatitis, and, rarely, leaking or secondarily infected hydatid cysts can cause fever and abdominal pain.</p></sec><sec id="s0120"><title>Jaundice</title><p id="p0375">Infections presenting with fever and jaundice are listed in <xref rid="t0020" ref-type="table">Table 150.3</xref>
.<table-wrap position="float" id="t0020"><label>TABLE 150.3</label><caption><p>Infectious Causes of Fever and Jaundice</p></caption><alt-text id="atte0035">TABLE 150.3</alt-text><table frame="hsides" rules="groups"><tbody><tr><td align="left">Hepatic</td><td align="left">EBV, CMV<break/>Enteric fever (typhoid and paratyphoid)<break/>Hepatitis A&#x02013;E<xref rid="tn0010" ref-type="table-fn">*</xref><break/>Leptospirosis (Weil's disease)<break/>Non-typhoidal <italic>Salmonella</italic> plus HIV<break/><italic>P. falciparum</italic> malaria, severe<break/>Relapsing fevers (<italic>Borrelia</italic> spp.)<break/>Septicemia, including pneumococcal sepsis<break/>Typhus<break/>Yellow fever and other viral hemorrhagic fevers</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Post-hepatic</td><td align="left">Ascending cholangitis (including occasionally helminths)</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Hemolytic</td><td align="left">Bartonellosis<break/>Hemolytic-uremic syndrome (<italic>Shigella</italic> spp., <italic>Escherichia coli</italic>)<break/>Malaria<break/><italic>Mycoplasma pneumoniae</italic><break/>Sickle cell crisis with infective trigger</td></tr></tbody></table><table-wrap-foot><fn><p><italic>CMV</italic>, Cytomegalovirus; <italic>EBV</italic>, Epstein&#x02013;Barr virus; <italic>HIV</italic>, human immunodeficiency virus.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tn0010"><label>*</label><p id="np0010">Fever and jaundice rarely present concurrently.</p></fn></table-wrap-foot><attrib>Table adapted with permission from British Infection Society. Fever in returned travelers presenting in the United Kingdom: recommendations for investigation and initial management.<xref rid="bib7" ref-type="bibr"><sup>5</sup></xref></attrib></table-wrap></p></sec></sec><sec id="s0125"><title>Neurologic Infections</title><p id="p0380">Neurologic presentations, including meningitis and encephalitis, are reported in 15/1000 ill returned travelers.<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> Cerebral malaria can present with encephalopathy, meningismus, seizures, or focal signs and should always be excluded.</p><sec id="s0130"><title>Meningitis</title><p id="p0385">Typical bacterial and viral causes should be considered. Causes of predominantly lymphocytic meningitis include arboviruses, brucellosis, leptospirosis, Lyme disease, Q fever, relapsing fevers, syphilis, tuberculosis, HIV seroconversion, and HIV-related opportunistic infections (e.g., cryptococcal meningitis). Some infections, such as enteric fever, rarely present with meningismus but the cerebrospinal fluid (CSF) is normal.</p></sec><sec id="s0135"><title>Encephalitis</title><p id="p0390">In addition to typical causes of encephalitis, travel-related causes are arboviruses (e.g., West Nile virus, Japanese encephalitis, tick-borne encephalitis), brucellosis, rabies, rickettsial infections, African trypanosomiasis, and tuberculosis. African trypanosomiasis (sleeping sickness) has been described in travelers returning from game parks in East and Central Africa, including Tanzania, Malawi, and Zambia.</p></sec></sec></sec><sec id="s0140"><title>Patient Evaluation, Diagnosis, and Differential Diagnosis</title><p id="p0395">It is necessary to understand the epidemiology of specific pathogens and to obtain the travel history, including geographic destinations visited, dates of risk exposures, time of onset, and duration of symptoms.<xref rid="bib5" ref-type="bibr"><sup>4</sup></xref> The geography of exposure helps determine which infections the traveler may have been exposed to, and illness onset and symptoms help to estimate the incubation period (see <xref rid="t0010" ref-type="table">Tables 150.1</xref> and <xref rid="t0015" ref-type="table">150.2</xref>).</p><p id="p0400">Many infections have similar clinical presentations; however, certain symptoms and signs can give clues; relevant examination findings include rash, eschar, hepatosplenomegaly, and jaundice (<xref rid="t0020" ref-type="table">TABLE 150.3</xref>, <xref rid="t0025" ref-type="table">TABLE 150.4</xref>, <xref rid="t0030" ref-type="table">TABLE 150.5</xref>
). <xref rid="t0035" ref-type="table">Table 150.6</xref>
lists the differential diagnosis in patients with chronic fever (&#x0003e;2 weeks) and is a reminder that non-infectious causes are seen in this group.<table-wrap position="float" id="t0025"><label>TABLE 150.4</label><caption><p>Infectious Causes of Acute Fever and Rash or Ulcer</p></caption><alt-text id="atte0040">TABLE 150.4</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Rash</th><th align="left">Infection</th></tr></thead><tbody><tr><td align="left">Maculopapular</td><td align="left">Arboviral infection (e.g., dengue, chikungunya, Zika)<break/>&#x0201c;Childhood viral illness&#x0201d; (e.g., measles, rubella, parvovirus)<break/>Drug hypersensitivity reaction<break/>Fungal infection (papule/nodules) (e.g., histoplasmosis, penicilliosis)<break/>Infectious mononucleosis group, e.g., EBV, CMV, HIV seroconversion<break/>Leprosy (reaction)<break/>Rickettsial infection (e.g., tick typhus)<break/>Syphilis<break/>Viral hemorrhagic fever (e.g., Ebola)</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Vesicular</td><td align="left">Herpes simplex virus, disseminated<break/>Herpes zoster virus (chickenpox or disseminated zoster)<break/>Monkey pox<break/>Rickettsial infection</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Erythroderma</td><td align="left">Dengue<break/>Chikungunya<break/>Zika<break/>Staphylococcal or streptococcal toxin&#x02013;related syndromes (e.g., toxic shock syndrome, scarlet fever)<break/>Sunburn<break/><italic>Vibrio vulnificus</italic></td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Purpuric</td><td align="left">Dengue hemorrhagic syndrome<break/>Gonococcal infection<break/>Herpes zoster virus, hemorrhagic<break/>Meningococcal infection<break/>Plague<break/>Rickettsial infection, severe<break/>Severe sepsis &#x000b1; disseminated intravascular coagulation<break/>Viral hemorrhagic fever (e.g., Lassa, Ebola, CCHF, Rift Valley fever)</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Pustule</td><td align="left">Herpes simplex virus, disseminated<break/>Herpes zoster virus (chickenpox or disseminated zoster)<break/>PVL-associated <italic>Staphylococcus aureus</italic></td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Ulcer</td><td align="left">Chancre: <italic>Trypanosoma rhodesiense, Yersinia pestis</italic> (bubonic plague)<break/>Eschar: African tick typhus, anthrax<break/>Genital ulcer: syphilis, herpes simplex virus<break/>Skin ulcer: anthrax, diphtheria, fungal infection, superinfected bacterial ulcer, tropical ulcer, Buruli ulcer</td></tr></tbody></table><table-wrap-foot><fn><p><italic>CCHF</italic>, Crimean-Congo hemorrhagic fever; <italic>CMV</italic>, cytomegalovirus; <italic>EBV</italic>, Epstein&#x02013;Barr virus; <italic>HIV</italic>, human immunodeficiency virus; <italic>PVL</italic>, Panton&#x02013;Valentine leukocidin.</p></fn></table-wrap-foot><attrib>Table adapted with permission from British Infection Society. Fever in returned travelers presenting in the United Kingdom: recommendations for investigation and initial management.<xref rid="bib7" ref-type="bibr"><sup>5</sup></xref></attrib></table-wrap><table-wrap position="float" id="t0030"><label>TABLE 150.5</label><caption><p>Infections Associated With Fever and Hepatomegaly, Splenomegaly, or Hepatosplenomegaly</p></caption><alt-text id="atte0045">TABLE 150.5</alt-text><table frame="hsides" rules="groups"><tbody><tr><td align="left">Bacterial</td><td align="left">Brucellosis<break/>Enteric fever (typhoid and paratyphoid)<break/>Leptospirosis<break/>Q fever (<italic>Coxiella burnetii</italic>)<break/>Relapsing fever (borreliosis)<break/>Rickettsial infection (e.g., tick typhus)</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Flukes</td><td align="left">Fascioliasis<break/>Schistosomiasis, acute (Katayama syndrome)</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Protozoal</td><td align="left">Amebic liver abscess<break/>Malaria (acute)<xref rid="tn0015" ref-type="table-fn">*</xref><break/>Trypanosomiasis<break/>Visceral leishmaniasis<xref rid="tn0015" ref-type="table-fn">*</xref></td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Viral</td><td align="left">Dengue<break/>Hepatitis, acute (A, B, E)<break/>HIV, CMV, or EBV seroconversion</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Non-infectious</td><td align="left">Chronic myeloid leukemia<xref rid="tn0015" ref-type="table-fn">*</xref><break/>Hemoglobinopathy<break/>Lymphoma<xref rid="tn0015" ref-type="table-fn">*</xref><break/>Myelofibrosis<xref rid="tn0015" ref-type="table-fn">*</xref></td></tr></tbody></table><table-wrap-foot><fn><p><italic>CMV</italic>, Cytomegalovirus; <italic>EBV</italic>, Epstein&#x02013;Barr virus; <italic>HIV</italic>, human immunodeficiency virus.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tn0015"><label>*</label><p id="np0015">Can cause massive splenomegaly.</p></fn></table-wrap-foot><attrib>Table adapted with permission from British Infection Society. Fever in returned travelers presenting in the United Kingdom: recommendations for investigation and initial management.<xref rid="bib7" ref-type="bibr"><sup>5</sup></xref></attrib></table-wrap><table-wrap position="float" id="t0035"><label>TABLE 150.6</label><caption><p>Infections Causing Chronic Fever (<bold>&#x0003e;</bold>14 Days)</p></caption><alt-text id="atte0050">TABLE 150.6</alt-text><table frame="hsides" rules="groups"><tbody><tr><td align="left">Bacterial</td><td align="left">Brucellosis<break/>Infective endocarditis<break/>Enteric fever (typhoid and paratyphoid)<break/>Pyogenic deep-seated abscess<break/>Q fever (<italic>Coxiella burnetii</italic>)<break/>Tuberculosis</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Fungal</td><td align="left">Coccidioidomycosis<break/>Cryptococcosis<break/>Histoplasmosis<break/>Paracoccidioidomycosis<break/>Penicilliosis</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Helminth</td><td align="left">Schistosomiasis, acute (Katayama syndrome)<break/><italic>Strongyloides</italic> hyper-infestation syndrome</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Protozoal</td><td align="left">Amebic liver abscess<break/>Toxoplasmosis<break/>Visceral leishmaniasis</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Viral</td><td align="left">HIV <italic>plus</italic> opportunistic infection</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Non-infectious</td><td align="left">Autoimmune disorders<break/>Drugs<break/>Malignancy<break/>Pulmonary embolus<break/>Vasculitis</td></tr></tbody></table><table-wrap-foot><fn><p><italic>HIV</italic>, Human immunodeficiency virus.</p></fn></table-wrap-foot><attrib>Table adapted with permission from British Infection Society. Fever in returned travelers presenting in the United Kingdom: recommendations for investigation and initial management.<xref rid="bib7" ref-type="bibr"><sup>5</sup></xref></attrib></table-wrap></p><p id="p0405">Travelers presenting with undifferentiated fever should have initial investigations (<xref rid="t0040" ref-type="table">Table 150.7</xref>
); following these, specific studies may be appropriate, depending on the differential diagnosis (<xref rid="t0045" ref-type="table">Table 150.8</xref>
). When tuberculosis is considered, it is essential that adequate samples of sputum or tissue for mycobacteria culture are obtained. Tuberculin skin tests and interferon-gamma release assays have a limited role in evaluation of patients with chronic fever.<table-wrap position="float" id="t0040"><label>TABLE 150.7</label><caption><p>Recommended Initial Investigations in Returning Travelers Presenting With (Undifferentiated) Fever<xref rid="tn0020" ref-type="table-fn">*</xref></p></caption><alt-text id="atte0055">TABLE 150.7</alt-text><table frame="hsides" rules="groups"><thead><tr><th align="left">Investigation</th><th align="left">Guidance and Interpretation</th></tr></thead><tbody><tr><td align="left">Malaria film and dipstick antigen test (RDT)</td><td align="left"><list list-type="simple" id="ulist0080"><list-item id="u0225"><label>&#x02022;</label><p id="p0410">Perform in all patients who have visited a tropical country within 1 year of presentation</p></list-item><list-item id="u0230"><label>&#x02022;</label><p id="p0415">The sensitivity of a thick film read by an expert is equivalent to that of an RDT; however, blood films are necessary for speciation and parasite count</p></list-item><list-item id="u0235"><label>&#x02022;</label><p id="p0420">Three thick films/RDTs over 72 hours (as an outpatient if appropriate) should be performed to exclude malaria with confidence</p></list-item><list-item id="u0240"><label>&#x02022;</label><p id="p0425">Positive blood films (thick and thin) should be sent to the reference laboratory for confirmation</p></list-item><list-item id="u0245"><label>&#x02022;</label><p id="p0430">Patients returned from Asia (particularly Malaysia) with a high <italic>P. malariae</italic> parasite count should have the potentially lethal <italic>P. knowlesi</italic> excluded by PCR</p></list-item></list></td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Complete blood count</td><td align="left"><list list-type="simple" id="ulist0085"><list-item id="u0250"><label>&#x02022;</label><p id="p0435">Lymphopenia: common in viral infection (dengue, HIV) and typhoid</p></list-item><list-item id="u0255"><label>&#x02022;</label><p id="p0440">Eosinophilia (&#x0003e;0.45 &#x000d7; 10<sup>9</sup>/L): incidental findings or indicative of infectious (e.g., parasitic, fungal) or non-infectious cause (see <xref rid="t0045" ref-type="table">Table 150.8</xref>)</p></list-item><list-item id="u0260"><label>&#x02022;</label><p id="p0445">Thrombocytopenia: malaria, dengue, acute HIV, typhoid; also seen in severe sepsis</p></list-item></list></td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Blood cultures</td><td align="left"><list list-type="simple" id="ulist0090"><list-item id="u0265"><label>&#x02022;</label><p id="p0450">Two sets should be taken before any antibiotic therapy</p></list-item><list-item id="u0270"><label>&#x02022;</label><p id="p0455">Sensitivity of up to 80% in typhoid</p></list-item><list-item id="u0275"><label>&#x02022;</label><p id="p0460">Notify the laboratory if the diagnosis of brucellosis is being considered</p></list-item></list></td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Liver function tests</td><td align="left">See <xref rid="t0030" ref-type="table">Table 150.5</xref></td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Serum save<xref rid="tn0025" ref-type="table-fn">&#x02020;</xref></td><td align="left"><list list-type="simple" id="ulist0095"><list-item id="u0280"><label>&#x02022;</label><p id="p0465">HIV testing should be offered to all patients, especially those with pneumonia, aseptic meningitis/encephalitis, diarrhea, viral hepatitis, mononucleosis-like syndrome, unexplained lymphadenopathy, fever, or blood dyscrasia</p></list-item><list-item id="u0285"><label>&#x02022;</label><p id="p0470">Other: consider a &#x0201c;geographic panel&#x0201d; for relevant other infections (e.g., arboviral, brucella, Q fever serology) if indicated</p></list-item></list></td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">EDTA sample for PCR<xref rid="tn0025" ref-type="table-fn">&#x02020;</xref></td><td align="left"><list list-type="simple" id="ulist0100"><list-item id="u0290"><label>&#x02022;</label><p id="p0475">Consider if other features suggestive of arboviral infection, VHF</p></list-item></list></td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">Urinalysis</td><td align="left"><list list-type="simple" id="ulist0105"><list-item id="u0295"><label>&#x02022;</label><p id="p0480">Proteinuria and hematuria in leptospirosis</p></list-item><list-item id="u0300"><label>&#x02022;</label><p id="p0485">Hemoglobinuria in malaria (rare)</p></list-item></list></td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">CXR &#x000b1; liver U/S</td><td align="left"/></tr></tbody></table><table-wrap-foot><fn><p><italic>CXR</italic>, Chest x-ray; <italic>HIV</italic>, human immunodeficiency virus; <italic>PCR</italic>, polymerase chain reaction; <italic>RDT</italic>, rapid diagnostic test; <italic>U/S</italic>, ultrasound; <italic>VHF,</italic> viral hemorrhagic fever.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tn0020"><label>*</label><p id="np0020">As an infection control precaution, the diagnosis of VHF should be considered and excluded before performing blood tests.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tn0025"><label>&#x02020;</label><p id="np0025">To ensure that the correct tests are done, an adequate travel history <italic>must</italic> be documented on request forms. This includes locations visited, dates of travel, dates of symptom onset, and risk activities undertaken. Pathogen-specific request forms may be required by reference laboratory for some infections (e.g., dengue and other arbovirus).</p></fn></table-wrap-foot><attrib>Table adapted with permission from British Infection Society. Fever in returned travelers presenting in the United Kingdom: recommendations for investigation and initial management.<xref rid="bib7" ref-type="bibr"><sup>5</sup></xref></attrib></table-wrap><table-wrap position="float" id="t0045"><label>TABLE 150.8</label><caption><p>Summary of Diagnostic Tools and Presumptive Therapy by Geographic Area of Travel and Clinical Presentation</p></caption><alt-text id="atte0060">TABLE 150.8</alt-text><graphic xlink:href="t150-008_p1-9780323555128"/><graphic xlink:href="t150-008_p2-9780323555128"/><table-wrap-foot><fn id="sp0105"><p>This table applies to patients in whom malaria has been excluded.</p></fn><fn id="sp0110"><p>Diseases that present commonly in non-travelers with fever are omitted: respiratory tract infections, diarrhea, EBV, lymphoma, etc.</p></fn></table-wrap-foot><attrib>Table adapted with permission from British Infection Society. Fever in returned travelers presenting in the United Kingdom: recommendations for investigation and initial management.<xref rid="bib7" ref-type="bibr"><sup>5</sup></xref></attrib></table-wrap></p><p id="p0490">Rarely, fever may be due to a viral hemorrhagic fever such as Lassa, Ebola, Marburg, or Crimean-Congo hemorrhagic fever. The diagnosis should be considered in travelers who have visited endemic regions within 21 days of symptom onset,<xref rid="bib34" ref-type="bibr">32</xref>, <xref rid="bib35" ref-type="bibr">33</xref> in particular, travel to rural areas of sub-Saharan Africa (particularly west and central Africa); contact with suspected cases, health care facilities, rats, or wild animals raises the index of suspicion. Symptoms and signs vary according to pathogen, with bleeding in advanced cases. These infections can be severe and have implications for nosocomial transmission. Diagnosis is by polymerase chain reaction (PCR) of blood, which should be performed prior to further investigations (which might result in exposure of health care staff); malaria must be excluded. A high index of suspicion, close liaison with specialists, and transfer to a specialist facility are usually necessary to manage these patients.</p><p id="p0495">One diagnostic strategy is to perform a standard &#x0201c;geographic panel&#x0201d; of diagnostic tests, based purely on the travel history, in all febrile patients in whom malaria has been excluded. This approach may reduce the likelihood that less common diagnoses are missed if a clinician does not consider them, but may also increase testing costs.</p></sec><sec id="s0145"><title>Treatment</title><p id="p0500">The relevant chapters should be consulted for detailed advice on the treatment of individual infections. Presumptive treatment may sometimes be started (see <xref rid="t0045" ref-type="table">Table 150.8</xref>).<xref rid="bib5" ref-type="bibr"><sup>4</sup></xref>
</p><sec id="s0150"><title>Malaria</title><p id="p0505">Parasitic confirmation (smears, rapid diagnostic tests [RDTs], or PCR) of suspected malaria is preferred, and empiric treatment is not recommended in clinical settings with good diagnostic facilities. However, diagnostic results must be accurate, timely, and available. Accuracy depends on the skills of the microscopist; RDT and PCR results reflect the performance characteristics of the assay. RDTs have high sensitivity for <italic>P. falciparum</italic> but can be lower for non-falciparum malaria. Presumptive treatment is not recommended, and facilities managing returning travelers should ensure an accurate diagnostic test result can be obtained within 6 hours.</p></sec><sec id="s0155"><title>Amebic Liver Abscess</title><p id="p0510">Metronidazole 750&#x0202f;mg three times daily for 7 to 10 days or tinidazole 2&#x0202f;g daily for 3 days should be started empirically in patients with an appropriate travel history, clinical presentation, imaging, and, where available, serology (can be falsely negative in early disease). Most patients demonstrate clinical improvement and resolution of fever within 48 to 72 hours. The main differential diagnosis is a pyogenic liver abscess; patients with sepsis require broad-spectrum antibiotics until the diagnosis is confirmed. Surgical or percutaneous drainage is rarely required and should only be considered if there is diagnostic uncertainty, symptoms persist after 4 days of treatment, or there is imminent risk of rupture into critical sites (e.g., left-lobe abscess rupturing into the pericardium).<xref rid="bib36" ref-type="bibr"><sup>34</sup></xref> After treatment, patients should be given 10 days of a luminal amebicide to prevent relapse: diloxanide furoate (500&#x0202f;mg orally three times daily) or paromomycin (30&#x0202f;mg/kg orally in three divided doses).</p></sec><sec id="s0160"><title>Enteric Fever</title><p id="p0515">When there is a strong suspicion, a parenteral third-generation cephalosporin (e.g., ceftriaxone) can be commenced pending blood culture results. Fluoroquinolone-resistant isolates are reported in patients returning from Asia, but so far have been rarely reported in those returning from Africa.<xref rid="bib37" ref-type="bibr"><sup>35</sup></xref> Ciprofloxacin 750&#x0202f;mg twice daily remains the treatment of choice for fully sensitive isolates. Azithromycin 1&#x0202f;g followed by 500&#x0202f;mg daily should be used as follow-on therapy where fluoroquinolone resistance is suspected or confirmed. Regardless of which antibiotic is used, fever can take time to resolve; failure to defervesce is not a reason to change antibiotics when the isolate is confirmed as sensitive.</p></sec><sec id="s0165"><title>Leptospirosis</title><p id="p0520">Due to the potential severity of the illness, the non-specific nature of initial investigations, and a minimum period of 6 to 10 days before confirmatory serology becomes available, a 5- to 7-day course of penicillin (benzylpenicillin 1.5 million units four times daily) or doxycycline (100&#x0202f;mg twice daily) should be considered in patients with a flulike illness within 7 to 12 days of freshwater exposure.</p></sec><sec id="s0170"><title>Rickettsiae</title><p id="p0525">Fever and headache, with or without rash, developing within 10 days of exposure to ticks in southern African game parks should prompt treatment with doxycycline 100&#x0202f;mg twice daily while other infections are excluded. A response is expected within 24 to 48 hours.</p></sec><sec id="s0175"><title>Acute Schistosomiasis</title><p id="p0530">Empiric treatment should be offered to travelers presenting with fever, urticarial rash, and eosinophilia (&#x0003e;0.45 &#x000d7; 10<sup>9</sup>/L) within 4 to 8 weeks of freshwater exposure.<xref rid="bib33" ref-type="bibr"><sup>31</sup></xref> Praziquantel 40&#x0202f;mg/kg in a divided dose 4 hours apart will kill mature, but not immature, schistosomes (<italic>Schistosoma japonicum:</italic> 60&#x0202f;mg/kg in three divided doses). Treatment should therefore be given at the time of diagnosis but repeated 6 to 8 weeks later. Corticosteroids can help alleviate acute symptoms.</p></sec><sec id="s0180"><title>Bacterial Sepsis</title><p id="p0535">International travel, particularly to India, the Middle East, and Africa, is associated with an increased risk of acquiring extended-spectrum &#x003b2;-lactamase&#x02013;producing gram-negative pathogens.<xref rid="bib38" ref-type="bibr"><sup>36</sup></xref> This should be taken into account when empiric antibiotics are indicated.</p></sec></sec></body><back><ref-list id="bb0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sr0010"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>DR</given-names></name></person-group><article-title>Health problems in a large cohort of Americans traveling to developing countries</article-title><source>J Travel Med</source><volume>7</volume><year>2000</year><fpage>259</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">11231210</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sr0015"><person-group person-group-type="author"><name><surname>Rack</surname><given-names>J</given-names></name><name><surname>Wichmann</surname><given-names>O</given-names></name><name><surname>Kamara</surname><given-names>B</given-names></name></person-group><article-title>Risk and spectrum of diseases in travelers to popular tourist destinations</article-title><source>J Travel Med</source><volume>12</volume><year>2005</year><fpage>248</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">16256047</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sr0020"><person-group person-group-type="author"><name><surname>Freedman</surname><given-names>DO</given-names></name><name><surname>Weld</surname><given-names>LH</given-names></name><name><surname>Kozarsky</surname><given-names>PE</given-names></name></person-group><article-title>Spectrum of disease and relation to place of exposure among ill returned travelers</article-title><source>N Engl J Med</source><volume>354</volume><year>2006</year><fpage>119</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">16407507</pub-id></element-citation></ref><ref id="bib5"><label>4</label><element-citation publication-type="journal" id="sr0025"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>ME</given-names></name><name><surname>Weld</surname><given-names>LH</given-names></name><name><surname>Boggild</surname><given-names>A</given-names></name></person-group><article-title>Fever in returned travelers: results from the GeoSentinel surveillance network</article-title><source>Clin Infect Dis</source><volume>44</volume><year>2007</year><fpage>1560</fpage><lpage>1568</lpage><pub-id pub-id-type="pmid">17516399</pub-id></element-citation></ref><ref id="bib7"><label>5</label><element-citation publication-type="journal" id="sr0030"><person-group person-group-type="author"><name><surname>Johnston</surname><given-names>V</given-names></name><name><surname>Stockley</surname><given-names>JM</given-names></name><name><surname>Dockrell</surname><given-names>D</given-names></name></person-group><article-title>Fever in returned travellers presenting in the United Kingdom: recommendations for investigation and initial management</article-title><source>J Infect</source><volume>59</volume><year>2009</year><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">19595360</pub-id></element-citation></ref><ref id="bib8"><label>6</label><element-citation publication-type="journal" id="sr0035"><person-group person-group-type="author"><name><surname>Schmid</surname><given-names>S</given-names></name><name><surname>Chiodini</surname><given-names>P</given-names></name><name><surname>Legros</surname><given-names>F</given-names></name></person-group><article-title>The risk of malaria in travellers to India</article-title><source>J Travel Med</source><volume>16</volume><issue>3</issue><year>2009</year><fpage>194</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">19538581</pub-id></element-citation></ref><ref id="bib9"><label>7</label><element-citation publication-type="journal" id="sr0040"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>AD</given-names></name><name><surname>Bradley</surname><given-names>DJ</given-names></name><name><surname>Smith</surname><given-names>V</given-names></name></person-group><article-title>Imported malaria and high risk groups: observational study using UK surveillance data 1987-2006</article-title><source>BMJ</source><volume>337</volume><year>2008</year><fpage>a120</fpage><pub-id pub-id-type="pmid">18599471</pub-id></element-citation></ref><ref id="bib10"><label>8</label><element-citation publication-type="journal" id="sr0045"><person-group person-group-type="author"><name><surname>Lalloo</surname><given-names>DG</given-names></name><name><surname>Shingadia</surname><given-names>D</given-names></name><name><surname>Bell</surname><given-names>DJ</given-names></name></person-group><article-title>UK malaria treatment guidelines</article-title><source>J Infect</source><volume>72</volume><year>2016</year><fpage>635</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">26880088</pub-id></element-citation></ref><ref id="bib11"><label>9</label><element-citation publication-type="journal" id="sr0050"><article-title>The effect of chemoprophylaxis on the timing of onset of falciparum malaria</article-title><source>Trop Med Int Health</source><volume>3</volume><year>1998</year><fpage>281</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">9623928</pub-id></element-citation></ref><ref id="bib12"><label>10</label><element-citation publication-type="journal" id="sr0055"><person-group person-group-type="author"><name><surname>Feasey</surname><given-names>NA</given-names></name><name><surname>Dougan</surname><given-names>G</given-names></name><name><surname>Kingsley</surname><given-names>RA</given-names></name></person-group><article-title>Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa</article-title><source>Lancet</source><volume>379</volume><issue>9835</issue><year>2012</year><fpage>2489</fpage><lpage>2499</lpage><pub-id pub-id-type="pmid">22587967</pub-id></element-citation></ref><ref id="bib13"><label>11</label><element-citation publication-type="journal" id="sr0060"><person-group person-group-type="author"><name><surname>Jensenius</surname><given-names>M</given-names></name><name><surname>Fournier</surname><given-names>PE</given-names></name><name><surname>Vene</surname><given-names>S</given-names></name></person-group><article-title>African tick bite fever in travelers to rural sub-equatorial Africa</article-title><source>Clin Infect Dis</source><volume>36</volume><year>2003</year><fpage>1411</fpage><lpage>1417</lpage><pub-id pub-id-type="pmid">12766836</pub-id></element-citation></ref><ref id="bib14"><label>12</label><element-citation publication-type="journal" id="sr0065"><person-group person-group-type="author"><name><surname>de Sousa</surname><given-names>R</given-names></name><name><surname>Nobrega</surname><given-names>SD</given-names></name><name><surname>Bacellar</surname><given-names>F</given-names></name></person-group><article-title>Torgal J. Mediterranean spotted fever in Portugal: risk factors for fatal outcome in 105 hospitalized patients</article-title><source>Ann N Y Acad Sci</source><volume>990</volume><year>2003</year><fpage>285</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">12860641</pub-id></element-citation></ref><ref id="bib15"><label>13</label><element-citation publication-type="journal" id="sr0070"><person-group person-group-type="author"><name><surname>Civen</surname><given-names>R</given-names></name><name><surname>Ngo</surname><given-names>V</given-names></name></person-group><article-title>Murine typhus: an unrecognized suburban vectorborne disease</article-title><source>Clin Infect Dis</source><volume>46</volume><year>2008</year><fpage>913</fpage><lpage>918</lpage><pub-id pub-id-type="pmid">18260783</pub-id></element-citation></ref><ref id="bib16"><label>14</label><element-citation publication-type="journal" id="sr0075"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>K</given-names></name><name><surname>Saxena</surname><given-names>VK</given-names></name><name><surname>Thomas</surname><given-names>TG</given-names></name><name><surname>Lal</surname><given-names>S</given-names></name></person-group><article-title>Outbreak investigation of scrub typhus in Himachal Pradesh (India)</article-title><source>J Commun Dis</source><volume>36</volume><year>2004</year><fpage>277</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">16506551</pub-id></element-citation></ref><ref id="bib17"><label>15</label><element-citation publication-type="journal" id="sr0080"><person-group person-group-type="author"><name><surname>Jelinek</surname><given-names>T</given-names></name><name><surname>Muhlberger</surname><given-names>N</given-names></name><name><surname>Harms</surname><given-names>G</given-names></name></person-group><article-title>Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNeteurop</article-title><source>Clin Infect Dis</source><volume>35</volume><year>2002</year><fpage>1047</fpage><lpage>1052</lpage><pub-id pub-id-type="pmid">12384837</pub-id></element-citation></ref><ref id="bib18"><label>16</label><element-citation publication-type="journal" id="sr0085"><person-group person-group-type="author"><name><surname>Burt</surname><given-names>FJ</given-names></name><name><surname>Rolph</surname><given-names>MS</given-names></name><name><surname>Rulli</surname><given-names>NE</given-names></name></person-group><article-title>Chikungunya: a re-emerging virus</article-title><source>Lancet</source><volume>379</volume><year>2012</year><fpage>662</fpage><lpage>671</lpage><pub-id pub-id-type="pmid">22100854</pub-id></element-citation></ref><ref id="bib19"><label>17</label><element-citation publication-type="journal" id="sr0090"><person-group person-group-type="author"><name><surname>Borgherini</surname><given-names>G</given-names></name><name><surname>Poubeau</surname><given-names>P</given-names></name><name><surname>Jossaume</surname><given-names>A</given-names></name></person-group><article-title>Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on Reunion Island</article-title><source>Clin Infect Dis</source><volume>47</volume><year>2008</year><fpage>469</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">18611153</pub-id></element-citation></ref><ref id="bib20"><label>18</label><element-citation publication-type="journal" id="sr0095"><person-group person-group-type="author"><name><surname>Brighton</surname><given-names>SW</given-names></name><name><surname>Prozesky</surname><given-names>OW</given-names></name><name><surname>de la Harpe</surname><given-names>AL</given-names></name></person-group><article-title>Chikungunya virus infection. A retrospective study of 107 cases</article-title><source>S Afr Med J</source><volume>63</volume><year>1983</year><fpage>313</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">6298956</pub-id></element-citation></ref><ref id="bib21"><label>19</label><element-citation publication-type="journal" id="sr0100"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>LR</given-names></name><name><surname>Jamieson</surname><given-names>DJ</given-names></name><name><surname>Powers</surname><given-names>AM</given-names></name></person-group><article-title>Zika virus</article-title><source>N Engl J Med</source><volume>374</volume><year>2016</year><fpage>1552</fpage><lpage>1563</lpage><pub-id pub-id-type="pmid">27028561</pub-id></element-citation></ref><ref id="bib22"><label>20</label><element-citation publication-type="journal" id="sr0105"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>VJ</given-names></name><name><surname>Chow</surname><given-names>A</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name></person-group><article-title>Simple clinical and laboratory predictors of chikungunya versus dengue infections in adults</article-title><source>PLoS Negl Trop Dis</source><volume>6</volume><year>2012</year><fpage>e1786</fpage><pub-id pub-id-type="pmid">23029573</pub-id></element-citation></ref><ref id="bib23"><label>21</label><element-citation publication-type="journal" id="sr0110"><person-group person-group-type="author"><name><surname>Bottieau</surname><given-names>E</given-names></name><name><surname>Clerinx</surname><given-names>J</given-names></name><name><surname>de Vega</surname><given-names>MR</given-names></name></person-group><article-title>Imported Katayama fever: clinical and biological features at presentation and during treatment</article-title><source>J Infect</source><volume>52</volume><year>2006</year><fpage>339</fpage><lpage>345</lpage><pub-id pub-id-type="pmid">16169593</pub-id></element-citation></ref><ref id="bib24"><label>22</label><element-citation publication-type="journal" id="sr0115"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>AR</given-names></name><name><surname>Ansdell</surname><given-names>VE</given-names></name><name><surname>Effler</surname><given-names>PV</given-names></name></person-group><article-title>Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974-1998</article-title><source>Clin Infect Dis</source><volume>33</volume><year>2001</year><fpage>1834</fpage><lpage>1841</lpage><pub-id pub-id-type="pmid">11692294</pub-id></element-citation></ref><ref id="bib25"><label>23</label><element-citation publication-type="journal" id="sr0120"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>SL</given-names><suffix>Jr</suffix></name></person-group><article-title>Amoebiasis</article-title><source>Lancet</source><volume>361</volume><year>2003</year><fpage>1025</fpage><lpage>1034</lpage><pub-id pub-id-type="pmid">12660071</pub-id></element-citation></ref><ref id="bib26"><label>24</label><element-citation publication-type="journal" id="sr0125"><person-group person-group-type="author"><name><surname>Pappas</surname><given-names>G</given-names></name><name><surname>Akritidis</surname><given-names>N</given-names></name><name><surname>Bosilkovski</surname><given-names>M</given-names></name><name><surname>Tsianos</surname><given-names>E</given-names></name></person-group><article-title>Brucellosis</article-title><source>N Engl J Med</source><volume>352</volume><year>2005</year><fpage>2325</fpage><lpage>2336</lpage><pub-id pub-id-type="pmid">15930423</pub-id></element-citation></ref><ref id="bib27"><label>25</label><element-citation publication-type="journal" id="sr0130"><person-group person-group-type="author"><name><surname>Raoult</surname><given-names>D</given-names></name><name><surname>Marrie</surname><given-names>T</given-names></name><name><surname>Mege</surname><given-names>J</given-names></name></person-group><article-title>Natural history and pathophysiology of Q fever</article-title><source>Lancet Infect Dis</source><volume>5</volume><year>2005</year><fpage>219</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">15792739</pub-id></element-citation></ref><ref id="bib28"><label>26</label><element-citation publication-type="journal" id="sr0135"><person-group person-group-type="author"><name><surname>Delsing</surname><given-names>CE</given-names></name><name><surname>Kullberg</surname><given-names>BJ</given-names></name></person-group><article-title>Q fever in the Netherlands: a concise overview and implications of the largest ongoing outbreak</article-title><source>Neth J Med</source><volume>66</volume><year>2008</year><fpage>365</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">18931396</pub-id></element-citation></ref><ref id="bib29"><label>27</label><element-citation publication-type="journal" id="sr0140"><person-group person-group-type="author"><name><surname>Matteelli</surname><given-names>A</given-names></name><name><surname>Carosi</surname><given-names>G</given-names></name></person-group><article-title>Sexually transmitted diseases in travelers</article-title><source>Clin Infect Dis</source><volume>32</volume><year>2001</year><fpage>1063</fpage><lpage>1067</lpage><pub-id pub-id-type="pmid">11264035</pub-id></element-citation></ref><ref id="bib30"><label>28</label><element-citation publication-type="journal" id="sr0145"><person-group person-group-type="author"><name><surname>Bottieau</surname><given-names>E</given-names></name><name><surname>Florence</surname><given-names>E</given-names></name><name><surname>Clerinx</surname><given-names>J</given-names></name></person-group><article-title>Fever after a stay in the tropics: clinical spectrum and outcome in HIV-infected travelers and migrants</article-title><source>J Acquir Immune Defic Syndr</source><volume>48</volume><year>2008</year><fpage>547</fpage><lpage>552</lpage><pub-id pub-id-type="pmid">18645519</pub-id></element-citation></ref><ref id="bib31"><label>29</label><element-citation publication-type="journal" id="sr0150"><person-group person-group-type="author"><name><surname>Arabi</surname><given-names>YM</given-names></name><name><surname>Balkhy</surname><given-names>HH</given-names></name><name><surname>Hayden</surname><given-names>FG</given-names></name></person-group><article-title>Middle East respiratory syndrome</article-title><source>N Engl J Med</source><volume>376</volume><year>2017</year><fpage>584</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">28177862</pub-id></element-citation></ref><ref id="bib32"><label>30</label><element-citation publication-type="journal" id="sr0155"><person-group person-group-type="author"><name><surname>Cobelens</surname><given-names>FG</given-names></name><name><surname>van Deutekom</surname><given-names>H</given-names></name><name><surname>Draayer-Jansen</surname><given-names>IW</given-names></name></person-group><article-title>Risk of infection with <italic>Mycobacterium tuberculosis</italic> in travellers to areas of high tuberculosis endemicity</article-title><source>Lancet</source><volume>356</volume><year>2000</year><fpage>461</fpage><lpage>465</lpage><pub-id pub-id-type="pmid">10981889</pub-id></element-citation></ref><ref id="bib33"><label>31</label><element-citation publication-type="journal" id="sr0160"><person-group person-group-type="author"><name><surname>Checkley</surname><given-names>AM</given-names></name><name><surname>Chiodini</surname><given-names>PL</given-names></name><name><surname>Dockrell</surname><given-names>DH</given-names></name></person-group><article-title>Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management</article-title><source>J Infect</source><volume>60</volume><year>2010</year><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">19931558</pub-id></element-citation></ref><ref id="bib34"><label>32</label><element-citation publication-type="journal" id="sr0165"><person-group person-group-type="author"><name><surname>Woodrow</surname><given-names>CJ</given-names></name><name><surname>Eziefula</surname><given-names>AC</given-names></name><name><surname>Agranoff</surname><given-names>D</given-names></name></person-group><article-title>Early risk assessment for viral haemorrhagic fever: experience at the hospital for tropical diseases, London, UK</article-title><source>J Infect</source><volume>54</volume><year>2007</year><fpage>6</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">16549203</pub-id></element-citation></ref><ref id="bib35"><label>33</label><element-citation publication-type="other" id="sr9000"><article-title>European Network for Diagnostics of Imported Viral Diseases</article-title><comment>Management and control of viral haemorrhagic fevers. 2nd version. May 2001</comment><ext-link ext-link-type="uri" xlink:href="http://www.enivd.de/netz.pdf" id="iw9000">http://www.enivd.de/netz.pdf</ext-link></element-citation></ref><ref id="bib36"><label>34</label><element-citation publication-type="journal" id="sr0175"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>R</given-names></name><name><surname>Hamid</surname><given-names>S</given-names></name><name><surname>Abid</surname><given-names>S</given-names></name></person-group><article-title>Predictive factors for early aspiration in liver abscess</article-title><source>World J Gastroenterol</source><volume>14</volume><year>2008</year><fpage>2089</fpage><lpage>2093</lpage><pub-id pub-id-type="pmid">18395912</pub-id></element-citation></ref><ref id="bib37"><label>35</label><element-citation publication-type="journal" id="sr0180"><person-group person-group-type="author"><name><surname>Cooke</surname><given-names>FJ</given-names></name><name><surname>Day</surname><given-names>M</given-names></name><name><surname>Wain</surname><given-names>J</given-names></name></person-group><article-title>Cases of typhoid fever imported into England, Scotland and Wales (2000-2003)</article-title><source>Trans R Soc Trop Med Hyg</source><volume>101</volume><year>2007</year><fpage>398</fpage><lpage>404</lpage><pub-id pub-id-type="pmid">17014877</pub-id></element-citation></ref><ref id="bib38"><label>36</label><element-citation publication-type="journal" id="sr0185"><person-group person-group-type="author"><name><surname>Woerther</surname><given-names>PL</given-names></name><name><surname>Andremont</surname><given-names>A</given-names></name><name><surname>Kantele</surname><given-names>A</given-names></name></person-group><article-title>Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level</article-title><source>J Travel Med</source><volume>24</volume><issue>suppl_1</issue><year>2017</year><fpage>S29</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">28520999</pub-id></element-citation></ref></ref-list></back></article>